1890208-58-8 Nootropics Powder 99% Compound 7P Intermediates In Pharmaceuticals
Place of Origin | CHINA |
---|---|
Brand Name | XRD |
Certification | GMP |
Model Number | 1890208-58-8 |
Minimum Order Quantity | negotiable |
Price | Inquiry for Negotiable |
Packaging Details | 1-2 Kg / Aluminum Foil Bag, 25kg/ Drum, as Require |
Delivery Time | 1-2days after payment received |
Payment Terms | T/T, Western Union,Bitcoin |
Supply Ability | 5000kg/year |

Contact me for free samples and coupons.
Whatsapp:0086 18588475571
Wechat: 0086 18588475571
Skype: sales10@aixton.com
If you have any concern, we provide 24-hour online help.
xPurity | 99% | Cas No. | 1890208-58-8 |
---|---|---|---|
Product NamRopivacainee | Compound 7P | Appearance | White Powder |
Assay | 99% Compound 7P | Grade | Pharmaceutical Grade |
Storage | Cool Dried Storage | Application | Pharmaceutical Raw Intermediates |
High Light | raw materials for pharma industry,intermediates in pharmaceuticals |
CAS 1890208-58-8 Pharmaceutical Intermediate Nootropics powder 99% Compound 7P
Description:
Chemical Name: 2-[(2-methoxyphenyl)[(4-methylphenyl)sulfonyl]amino]-N-(4-methoxy-3-pyridinyl)acetamide ;2-(N-(2-methoxyphenyl)-4-methylphenylsulfonamido)-N-(4-methoxypyridin-3-yl)acetamide
CAS No.: 1890208-58-8
Reaxys Registry Number: 29568294
Molecular Formula: C22H23N3O5S
Molecular Weight: 441.508
Assay:99%min
InChI Key: NAXWKPFXCOBXLE-UHFFFAOYSA-N
Density(Predicted): 1.329±0.06 g/cm3 |Condition:Temp:20 Press:760Torr
Function:
Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential , and one of the strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways.here we report phenotypic cell-based screen of chemical libraries and structure-activity-guided optimization that resulted in the identification of compound 7p which promotes neurite outgrowth of cultured primary neurons derived from the hippocampus, cerebral cortex, and retina. in an animal model of optic nerve injury, compound 7p was shown to induce growth of gap-43 positive axons, indicating that the in vitro neurite outgrowth activity of compound 7p translates into stimulation of axon regeneration in vivo.further optimization of compound 7p and elucidation of the mechanisms by which it elicits axon regeneration in vivo will provide a rational basis for future efforts to enhance treatment strategies.
Packing:
CAS 1890208-58-8 Pharmaceutical Intermediate Nootropics powder 99% Compound 7P